Methionine Adenosyltransferase Engineering to Enable Bioorthogonal Platforms for AdoMet-Utilizing Enzymes. 2020

Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States.

The structural conservation among methyltransferases (MTs) and MT functional redundancy is a major challenge to the cellular study of individual MTs. As a first step toward the development of an alternative biorthogonal platform for MTs and other AdoMet-utilizing enzymes, we describe the evaluation of 38 human methionine adenosyltransferase II-α (hMAT2A) mutants in combination with 14 non-native methionine analogues to identify suitable bioorthogonal mutant/analogue pairings. Enabled by the development and implementation of a hMAT2A high-throughput (HT) assay, this study revealed hMAT2A K289L to afford a 160-fold inversion of the hMAT2A selectivity index for a non-native methionine analogue over the native substrate l-Met. Structure elucidation of K289L revealed the mutant to be folded normally with minor observed repacking within the modified substrate pocket. This study highlights the first example of exchanging l-Met terminal carboxylate/amine recognition elements within the hMAT2A active-site to enable non-native bioorthgonal substrate utilization. Additionally, several hMAT2A mutants and l-Met substrate analogues produced AdoMet analogue products with increased stability. As many AdoMet-producing (e.g., hMAT2A) and AdoMet-utlizing (e.g., MTs) enzymes adopt similar active-site strategies for substrate recognition, the proof of concept first generation hMAT2A engineering highlighted herein is expected to translate to a range of AdoMet-utilizing target enzymes.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008716 Methionine Adenosyltransferase An enzyme that catalyzes the synthesis of S-adenosylmethionine from methionine and ATP. EC 2.5.1.6. S-Adenosylmethionine Synthetase,ATP-Methionine S-Adenosyltransferase,ATP Methionine S Adenosyltransferase,Adenosyltransferase, Methionine,S Adenosylmethionine Synthetase,S-Adenosyltransferase, ATP-Methionine,Synthetase, S-Adenosylmethionine
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012436 S-Adenosylmethionine Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed) AdoMet,Ademetionine,FO-1561,Gumbaral,S Amet,S-Adenosyl-L-Methionine,S-Adenosylmethionine Sulfate Tosylate,SAM-e,Samyr,FO 1561,FO1561,S Adenosyl L Methionine,S Adenosylmethionine,S Adenosylmethionine Sulfate Tosylate
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
January 2024, Methods in molecular biology (Clifton, N.J.),
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
February 2016, Proceedings of the National Academy of Sciences of the United States of America,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
December 1976, Biochemical medicine,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
November 1973, Molecular & general genetics : MGG,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
January 2011, Advances in enzymology and related areas of molecular biology,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
October 1975, Biochemical and biophysical research communications,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
August 1993, Pharmacology & therapeutics,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
August 1972, Biochimica et biophysica acta,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
February 2021, ACS medicinal chemistry letters,
Tyler D Huber, and Jonathan A Clinger, and Yang Liu, and Weijun Xu, and Mitchell D Miller, and George N Phillips, and Jon S Thorson
April 1979, Biochemical medicine,
Copied contents to your clipboard!